Cost-contained regulatory compliance for the pharmaceutical, biologics, and medical device industries von Weinberg, Sandy

DE-861
DE-473
URL des Erstveröffentlichers

Cost-contained regulatory compliance for the pharmaceutical, biologics, and medical device industries von Weinberg, Sandy 1950-

Drug truths dispelling the myths about pharma R & D von LaMattina, John L.

DE-861
DE-473
URL des Erstveröffentlichers

One political economy, one competitive strategy? comparing pharmaceutical firms in Germany, Italy, and the UK von Herrmann, Andrea M.

Profits before people? ethical standards and the marketing of prescription drugs von Weber, Leonard J.

DE-1046
DE-1047
Volltext

Taking Your Medicine Drug Regulation in the United States von Temin, Peter 1937-

DE-1043
DE-1046
DE-858
DE-Aug4
DE-859
DE-860
DE-473
DE-739
Volltext

Cost-contained regulatory compliance for the pharmaceutical, biologics, and medical device industries von Weinberg, Sandy

DE-1046
DE-1047
Volltext

Cost-contained regulatory compliance for the pharmaceutical, biologics, and medical device industries von Weinberg, Sandy

Volltext

The Impact of regulation on the development of new products in the pharmaceutical sector New products and services. analysis of regulations shaping new markets : first interim repo...

New products and services. analysis of regulations shaping new markets : second interim report

Administered prices, drugs report of the Committee on the Judiciary, United States Senate, by its Subcommittee on Antitrust and Monopoly, pursuant to S. Res. 52. 87,1. Congress ...